Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Help Clarify

Feb 10, 2007 05:52PM

Feb 10, 2007 09:05PM

Feb 11, 2007 01:33AM

Feb 11, 2007 03:41AM

Feb 17, 2007 11:37AM

Feb 17, 2007 11:48AM

Feb 17, 2007 01:55PM

Opps sorry about the prior blank post.

Toshiba and NEC separately requested patent review. Based on that, one would expect that the primary defense is prior art/obviousness.  Are we now saying prior art/obiousness is no longer part of the J2 defense?  I read through the defenses and did not see it, but not sure if I would recognize it. Can anyone with expertise in legaleze and familiar with all the filings please confirm that this is indeed the case. Many thanks in advance. opty

Share
New Message
Please login to post a reply